
from
Independent International Investment Research3 page report
published Oct 29, 2009
Price
$15.00 available for immediate download
Report Overview
Search Inside
About
Independent International Inve...
Novo Nordisk A.S. (Novo Nordisk) reported robust y-o-y revenue growth in 3Q 09, reflecting higher sales from both segments. Revenues were in line with our expectations while operating...
|
| Source: | IIR Group PLC
|
| Document ID: | GER25538SN
|
| Country: | Denmark
|
| Industry: | Pharmaceutical
|
| Ticker: | NOVO.B=DK
|
| Primary ISIN: | US6701002056
|
| Primary Sedol: | 2651202
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
Independent International Investment Research is the UK's leading source of truly impartial research and strategy for global equities and currencies.